Overview

Gastric Modulator (TANTALUS® System) Versus Insulin Treatment in Obese Type 2 Diabetic Patients - a Randomized Control Trial

Status:
Unknown status

Trial end date:
2011-10-01

Target enrollment:

Participant gender:

Summary

This study aims to analyze the pre- and post-operative clinical, hormonal and biochemical changes in moderately obese type 2 diabetic patients who are sub-optimally controlled on at least 2 anti-diabetic agents. Study participants will either receive implantation of the gastric contraction modulator or conventional treatment with insulin therapy.

Phase:

Phase 3

Details

Lead Sponsor:

Chinese University of Hong Kong

Collaborators:

Metacure
MetaCure Limited

Treatments:

Insulin
Insulin, Globin Zinc